# SEC Litigation Release LR-18756

> Civil enforcement action · 2004-06-21

## Defendants

Helvetia Pharmaceuticals, Inc., Richard A. Anders, Nicholas Bachynsky, Arthur Scheinert, and Laurence Dean



## Key facts

- **Release number:** LR-18756
- **Release date:** 2004-06-21
- **Defendants:** Helvetia Pharmaceuticals, Inc., Richard A. Anders, Nicholas Bachynsky, Arthur Scheinert, and Laurence Dean

## Primary sources

- SEC HTML release: https://www.sec.gov/litigation/litreleases/2004/lr18756.htm
- Litigation releases index: https://www.sec.gov/litigation/litreleases

## What this is

SEC Litigation Releases are the canonical "civil enforcement" docket. The SEC files civil actions in federal court against individuals and entities for securities-law violations — fraud, insider trading, Ponzi schemes, registration violations, misleading disclosures, market manipulation. Each release announces a filing, a settlement, or a final judgment. Activist funds, plaintiff lawyers, and investigative journalists use this archive as the most-comprehensive index of US securities enforcement.

## Citation

> US Securities and Exchange Commission, Litigation Release LR-18756 (2004-06-21), Helvetia Pharmaceuticals, Inc., Richard A. Anders, Nicholas Bachynsky, Arthur Scheinert, and Laurence Dean. Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/sec-litigation/18756.

---

*[SEC litigation releases dataset](/datasets/sec-litigation-releases) · CC0 1.0*